1.20

8.40% -0.11

Accendra Health Inc (ACH)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Storia dei dividendi

Precedente Chiudi:

$1.31

Aprire:

$1.28

Volume 24 ore:

1.69M

Relative Volume:

1.55

Capitalizzazione di mercato:

$92.29M

Reddito:

$4.72B

Utile/perdita netta:

$-123.85M

Rapporto P/E:

-0.0839

EPS:

-14.2981

Flusso di cassa netto:

$-303.12M

1 W Prestazione:

+26.20%

1M Prestazione:

-64.91%

6M Prestazione:

-54.02%

1 anno Prestazione:

-82.02%

Intervallo 1D:

$1.175

$1.31

Intervallo di 1 settimana:

$0.95

$1.37

Portata 52W:

$0.9337

$4.6887

Accendra Health Inc Stock (ACH) Company Profile

Nome

Accendra Health Inc

Settore

Healthcare (1080)

Industria

Medical Distribution (12)

Telefono

(804) 277-4304

Indirizzo

4435 WATERFRONT DRIVE, GLEN ALLEN

Dipendente

6,500

Cinguettio

Prossima data di guadagno

2026-08-10

Ultimi documenti SEC

ACH's Discussions on Twitter

Compare ACH vs MCK, COR, CAH, HSIC, AHG

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ACH Accendra Health Inc	1.20	100.75M	4.72B	-123.85M	-303.12M	-14.30
MCK Mckesson Corp	858.90	97.79B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	318.04	60.05B	328.68B	2.55B	1.56B	13.03
CAH Cardinal Health Inc	229.51	53.13B	250.74B	1.55B	4.39B	6.5398
HSIC Henry Schein Inc	88.50	9.86B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	0.9297	873.84M	14.85M	-136.07M	7.25M	-0.4726

Accendra Health Inc Stock (ACH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-03	Downgrade	UBS	Buy → Neutral
2024-07-19	Aggiornamento	Citigroup	Neutral → Buy
2024-02-26	Iniziato	Leerink Partners	Market Perform
2024-01-03	Iniziato	Barclays	Equal Weight
2022-10-13	Downgrade	Citigroup	Buy → Neutral
2022-10-12	Downgrade	BofA Securities	Buy → Underperform
2022-10-12	Downgrade	Robert W. Baird	Outperform → Neutral
2022-04-26	Ripresa	Citigroup	Buy
2022-04-01	Ripresa	Credit Suisse	Neutral
2022-03-30	Ripresa	JP Morgan	Underweight
2022-03-23	Aggiornamento	HSBC Securities	Reduce → Hold
2021-04-08	Aggiornamento	JP Morgan	Neutral → Overweight
2021-03-08	Aggiornamento	Goldman	Sell → Buy
2020-12-17	Aggiornamento	UBS	Neutral → Buy
2020-09-25	Aggiornamento	Barclays	Underweight → Equal Weight
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-07-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2020-07-14	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-05-05	Downgrade	Robert W. Baird	Outperform → Neutral
2020-04-23	Ripresa	Credit Suisse	Neutral
2020-01-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2020-01-07	Downgrade	Goldman	Neutral → Sell
2019-11-15	Aggiornamento	CLSA	Underperform → Outperform
2019-09-06	Reiterato	BofA/Merrill	Neutral
2019-04-10	Reiterato	BofA/Merrill	Neutral
2019-04-03	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-04-01	Aggiornamento	JP Morgan	Underweight → Overweight
2019-01-18	Aggiornamento	HSBC Securities	Hold → Buy
2019-01-17	Iniziato	UBS	Neutral
2019-01-15	Aggiornamento	CLSA	Underperform → Outperform
2018-12-14	Downgrade	Morgan Stanley	Overweight → Underweight
2018-12-12	Downgrade	Goldman	Buy → Neutral
2018-09-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-04-11	Downgrade	CLSA	Outperform → Sell
2018-04-10	Aggiornamento	Credit Suisse	Neutral → Outperform
2018-03-26	Aggiornamento	Goldman	Sell → Neutral
2017-11-02	Downgrade	HSBC Securities	Buy → Hold
2016-03-24	Aggiornamento	Goldman	Sell → Neutral
2015-12-07	Downgrade	Goldman	Neutral → Sell
2015-08-31	Aggiornamento	Credit Suisse	Underperform → Neutral
2012-08-01	Iniziato	HSBC Securities	Underweight
2009-08-05	Aggiornamento	Citigroup	Sell → Buy
2008-12-01	Downgrade	HSBC Securities	Neutral → Underweight

Mostra tutto

Accendra Health Inc Borsa (ACH) Ultime notizie

Aug 19, 2026

Accendra (ACH) Quarterly Figures: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Stock Move: The Stock Gains 5.61% for the Current SessionBasic EPS Analysis - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Accendra Health Inc (NYSE: ACH) Share Price, ACH Stock News, ACH Share Price & Updates - Kalkine

Aug 18, 2026

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com South Africa

Aug 17, 2026

Accendra Health Drops Equity Issuance Plan, Targets September CEO Announcement - citybiz

Aug 17, 2026

Accendra Health drops equity issuance plan as CEO succession process advances - Yahoo Finance

Aug 17, 2026

Accendra Health scraps equity program, expects CEO successor - Investing.com

Aug 17, 2026

Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Nigeria

Aug 17, 2026

Accendra Health sells first of two non-core assets, expects about $45 million cash injection - Bitget

Aug 17, 2026

Accendra Health to forgo ATM program, sees ~$45M from two asset sales; CEO successor expected by mid-September - TradingView

Aug 17, 2026

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans - Yahoo Finance

Aug 17, 2026

Aug 14, 2026

Accendra Health ready to put weak Q2 in rear view - HME News

Aug 14, 2026

Accendra Health (ACH) Drops 9% to $1.10 as Selling Pressure PersistsAnchored VWAP - vinanet.vn

Aug 14, 2026

Accendra Health 2Q Loss/Shr $1.16 >ACH - Moomoo

Aug 14, 2026

Aug 12, 2026

Accendra Health (NYSE:ACH) Rating Lowered to "Hold" at Robert W. Baird - MarketBeat

Aug 12, 2026

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH - MarketBeat

Aug 12, 2026

Aug 11, 2026